MedX Health Corp
MDXHF
$0.0008
$0.000.00%
| Weiss Ratings | MDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | MDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | MDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.56 | |||
| Price History | MDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | -98.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -97.71% | |||
| 2-Year Total Return | -98.00% | |||
| 3-Year Total Return | -98.40% | |||
| 5-Year Total Return | -98.08% | |||
| 52-Week High % Change | -98.55% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | MDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.06 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Nov 13, 2024 | |||
| 52-Week High Price (Date) | May 21, 2024 | |||
| Valuation | MDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 11.27M | |||
| Enterprise Value | 16.26M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -58.33% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.80 | |||
| Price/Book (Q) | -0.03 | |||
| Enterprise Value/Revenue (TTM) | 52.47 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -7.53 | |||
| Enterprise Value/EBIT | -7.42 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | MDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 269.98M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 905 670 4428 | |||
| Address | 1495 Bonhill Road Mississauga, ON L5T 1M2 | |||
| Website | www.medxhealth.com | |||
| Country | Canada | |||
| Year Founded | 1999 | |||
| Profitability | MDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -707.39% | |||
| Profit Margin | -855.61% | |||
| Management Effectiveness | MDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -197.11% | |||
| Return on Equity | -- | |||
| Income Statement | MDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 270.60K | |||
| Total Revenue (TTM) | 270.60K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 90.40K | |||
| EBITDA (TTM) | -1.89M | |||
| EBIT (TTM) | -1.91M | |||
| Net Income (TTM) | -2.32M | |||
| Net Income Avl. to Common (TTM) | -2.32M | |||
| Total Revenue Growth (Q YOY) | -19.90% | |||
| Earnings Growth (Q YOY) | 50.09% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 64.81% | |||
| Balance Sheet | MDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 114.30K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 610.40K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -6.64M | |||
| Current Ratio (Q) | 0.093 | |||
| Book Value Per Share (Q) | -$0.02 | |||
| Total Assets (Q) | 648.20K | |||
| Total Current Liabilities (Q) | 6.55M | |||
| Total Debt (Q) | 5.43M | |||
| Total Liabilities (Q) | 7.29M | |||
| Total Common Equity (Q) | -6.64M | |||
| Cash Flow | MDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 1.83M | |||
| Net Change in Cash (TTM) | -24.00K | |||
| Levered Free Cash Flow (TTM) | -1.79M | |||
| Cash from Operations (TTM) | -1.86M | |||
